Top

BMC Musculoskeletal Disorders

Published in:

Open Access 01-12-2014 | Research article

Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement

Authors: Zhen-hua Gao, Jun-qiang Yin, Xian-biao Xie, Chang-ye Zou, Gang Huang, Jin wang, Jing-nan Shen

Published in: BMC Musculoskeletal Disorders | Issue 1/2014

Abstract

Background

Aggressive curettage has been well established for the treatment of giant cell tumors (GCTs) of the bone. The purpose of this study was to review our experience and evaluate the role of different implant materials in patients with GCTs of the extremities after aggressive curettage.

Methods

A total of 119 patients with GCTs of the long bone were treated at the First Affiliated Hospital of Sun Yat-Sen University between 2004 and 2009. We excluded patients presenting metastases, recurrent tumors, and soft tissue involvement and those with Jaffe pathological grade III. The remaining 65 patients were treated with aggressive curettage using a bone graft or bone cement to fill the cavity. The recurrence rates and functional scores associated with the different fillings were analyzed.

Results

Aggressive curettage and bone grafting was performed in 34 cases (52.3%), and aggressive curettage with bone cement was performed in 31 cases (47.7%). The overall recurrence rate after the aggressive intralesional procedures was 35.3% with bone grafting and 12.9% when bone cement was used as an adjuvant filling. The recurrence rate following aggressive curettage and bone grafting was higher than that following aggressive curettage with cement (p = 0.038). The Musculoskeletal Tumor Society (MSTS) score for bone graft patients was 91.1%, which was significantly lower than that for patients treated with bone cement (94.7%).

Conclusions

The use of bone cement was associated with a significantly lower recurrence rate than bone grafting following aggressive intralesional curettage to treat benign giant cell tumors of the long bone. Better MSTS functional results were also observed in the bone cement group compared to the bone graft group.

Available only for authorised users

Campanacci M, Baldini N, Boriani S, Sudanese A: Giant-cell tumor of bone. J Bone Joint Surg Am. 1987, 69: 106-114.PubMed

Yasko AW: Giant cell tumor of bone. Curr Oncol Rep. 2002, 4: 520-526. 10.1007/s11912-002-0067-2.CrossRefPubMed

Domovitov SV, Healey JH: Primary malignant giant-cell tumor of bone has high survival rate. Ann Surg Oncol. 2010, 17: 694-701. 10.1245/s10434-009-0803-z.CrossRefPubMed

Mendenhall WM, Zlotecki RA, Scarborough MT, Gibbs CP, Mendenhall NP: Giant cell tumor of bone. Am J Clin Oncol. 2006, 29: 96-99. 10.1097/01.coc.0000195089.11620.b7.CrossRefPubMed

Raskin KA, Schwab JH, Mankin HJ, Springfield DS, Hornicek FJ: Giant cell tumor of bone. J Am Acad Orthop Surg. 2013, 21: 118-126. 10.5435/JAAOS-21-02-118.CrossRefPubMed

Campanacci M, Capanna R, Fabbri N, Bettelli G: Curettage of giant cell tumor of bone. Reconstruction with subchondral grafts and cement. Chir Organi Mov. 1990, 75: 212-213.PubMed

Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G: Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol. 2008, 134: 969-978. 10.1007/s00432-008-0370-x.CrossRefPubMed

Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P, Folleras G: Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop. 2008, 79: 86-93. 10.1080/17453670710014815.CrossRefPubMed

Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH: Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res. 2011, 469: 591-599. 10.1007/s11999-010-1501-7.CrossRefPubMed

10.

Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS: Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am. 1999, 81: 811-820.CrossRefPubMed

11.

Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, Moreau G, Davis AM: Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res. 2002, 397: 248-258.CrossRefPubMed

12.

Niu X, Zhang Q, Hao L, Ding Y, Li Y, Xu H, Liu W: Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. J Bone Joint Surg Am. 2012, 94: 461-467.CrossRefPubMed

13.

Becker WT, Dohle J, Bernd L, Braun A, Cserhati M, Enderle A, Hovy L, Matejovsky Z, Szendroi M, Trieb K, Tunn PU: Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am. 2008, 90: 1060-1067.CrossRefPubMed

14.

Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, Rossi G, Longhi A, Mercuri M: Giant cell tumor of the extremity: a review of 349 cases from a single institution. Cancer Treat Rev. 2010, 36: 1-7. 10.1016/j.ctrv.2009.09.002.CrossRefPubMed

15.

JaVe HL, Lichtenstein L, Portis RB: Giant cell tumor of bone. Its pathologic appearance, grading, supposed variants and treatment. Arch Pathol. 1940, 30: 993-1031.

16.

Bieling P, Rehan N, Winkler P, Helmke K, Maas R, Fuchs N, Bielack S, Heise U, Jurgens H, Treuner J, Romanowski R, Exner U, Kotz R, Winkler K: Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol. 1996, 14: 848-858.PubMed

17.

Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ: A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993, 286: 241-246.PubMed

18.

Wulling M, Engels C, Jesse N, Werner M, Delling G, Kaiser E: The nature of giant cell tumor of bone. J Cancer Res Clin Oncol. 2001, 127: 467-474. 10.1007/s004320100234.CrossRefPubMed

19.

Chakarun CJ, Forrester DM, Gottsegen CJ, Patel DB, White EA, Matcuk GR: Giant cell tumor of bone: review, mimics, and new developments in treatment. Radiographics. 2013, 33: 197-211. 10.1148/rg.331125089.CrossRefPubMed

20.

Goldring SR, Schiller AL, Mankin HJ, Dayer JM, Krane SM: Characterization of cells from human giant cell tumors of bone. Clin Orthop Relat Res. 1986, 204: 59-75.PubMed

21.

Cowan RW, Singh G: Giant cell tumor of bone: a basic science perspective. Bone. 2013, 52: 238-246. 10.1016/j.bone.2012.10.002.CrossRefPubMed

22.

Scully SP, Mott MP, Temple HT, O’Keefe RJ, O’Donnell RJ, Mankin HJ: Late recurrence of giant-cell tumor of bone. A report of four cases. J Bone Joint Surg Am. 1994, 76: 1231-1233.PubMed

23.

Trieb K, Bitzan P, Lang S, Dominkus M, Kotz R: Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy. Eur J Surg Oncol. 2001, 27: 200-202. 10.1053/ejso.2000.1086.CrossRefPubMed

24.

Prosser GH, Baloch KG, Tillman RM, Carter SR, Grimer RJ: Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone. Clin Orthop Relat Res. 2005, 435: 211-218.CrossRefPubMed

25.

Wang HC, Chien SH, Lin GT: Management of grade III giant cell tumors of bones. J Surg Oncol. 2005, 92: 46-51. 10.1002/jso.20338.CrossRefPubMed

26.

Malek F, Krueger P, Hatmi ZN, Malayeri AA, Faezipour H, O’Donnell RJ: Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy. Int Orthop. 2006, 30: 495-498. 10.1007/s00264-006-0146-3.CrossRefPubMedPubMedCentral

27.

Szendroi M, Kiss J, Antal I: Surgical treatment and prognostic factors in giant-cell tumor of bone. Acta Chir Orthop Traumatol Cech. 2003, 70: 142-150.PubMed

28.

Krishnan EC, Nelson C, Neff JR: Thermodynamic considerations of acrylic cement implant at the site of giant cell tumors of the bone. Med Phys. 1986, 13: 233-239. 10.1118/1.595902.CrossRefPubMed

29.

Nelson DA, Barker ME, Hamlin BH: Thermal effects of acrylic cementation at bone tumour sites. Int J Hyperthermia. 1997, 13: 287-306. 10.3109/02656739709023537.CrossRefPubMed

30.

Sakayama K, Sugawara Y, Kidani T, Miyawaki J, Fujibuchi T, Kamei S, Aizawa J, Yamamoto H: Diagnostic and therapeutic problems of giant cell tumor in the proximal femur. Arch Orthop Trauma Surg. 2007, 127: 867-872. 10.1007/s00402-007-0419-3.CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/15/330/prepub

Title: Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement
Authors: Zhen-hua Gao
Jun-qiang Yin
Xian-biao Xie
Chang-ye Zou
Gang Huang
Jin wang
Jing-nan Shen
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: BMC Musculoskeletal Disorders / Issue 1/2014
Electronic ISSN: 1471-2474
DOI: https://doi.org/10.1186/1471-2474-15-330

At a glance: The STEP trials

Springer Medicine

Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Prevalence of low back pain by anatomic location and intensity in an occupational population

Rationale, design and methods of the Study of Work and Pain (SWAP): a cluster randomised controlled trial testing the addition of a vocational advice service to best current primary care for patients with musculoskeletal pain (ISRCTN 52269669)

Evidence for the role of connexin 43-mediated intercellular communication in the process of intracortical bone resorption via osteocytic osteolysis

Treatment of osteoblastoma at C3-4 in a child: a case report

Rationale and design of the INNOVATE Trial: an international cooperative study on surgical versus conservative treatment for odontoid fractures in the elderly

Limb function and quality of life after various reconstruction methods according to tumor location following resection of osteosarcoma in distal femur